Localization of MPP+ binding sites in the brain of various mammalian species

[1]  M. Herkenham,et al.  Selective retention of MPP+ within the monoaminergic systems of the primate brain following MPTP administration: An in vivo autoradiographic study , 1991, Neuroscience.

[2]  M. Zompo,et al.  [3H]1‐Methyl‐4‐Phenyl‐2,3‐Dihydropyridinium Ion Binding Sites in Mouse Brain: Pharmacological and Biological Characterization , 1990, Journal of neurochemistry.

[3]  R. Olsen,et al.  MPTP is proconvulsant acutely but has no long-term effect in rodent models of seizure and epilepsy , 1989, Brain Research.

[4]  R. Fariello,et al.  MPTP and convulsive responses in rodents , 1987, Brain Research.

[5]  R. Cohen,et al.  MPP+ (1-methyl-4-phenylpyridine) is a neurotoxin to dopamine-, norepinephrine- and serotonin-containing neurons. , 1987, European journal of pharmacology.

[6]  R. Maggio,et al.  High affinity binding sites for 1-methyl-4-phenyl-pyridinium ion (MPP+) are present in mouse brain. , 1986, European journal of pharmacology.

[7]  U. Bonuccelli,et al.  Involvement of monoamine oxidase enzymes in the action of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine, a selective neurotoxin, in the squirrel monkey: Binding and biochemical studies , 1986, Brain Research.

[8]  S. Snyder,et al.  Selectivity of the parkinsonian neurotoxin MPTP: toxic metabolite MPP+ binds to neuromelanin. , 1986, Science.

[9]  A. J. Bradbury,et al.  1-Methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathway , 1986, Nature.

[10]  R. Fuller,et al.  Influence of selective, reversible inhibitors of monoamine oxidase on the prolonged depletion of striatal dopamine by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. , 1985, Life sciences.

[11]  M. Zompo,et al.  1 ‐Methyl‐4‐Phenyl‐ 1,2,3,6‐Tetrahydropyridine: Correspondence of Its Binding Sites to Monoamine Oxidase in Rat Brain, and Inhibition of Dopamine Oxidative Deamination In Vivo and In Vitro , 1985, Journal of neurochemistry.

[12]  S. Snyder,et al.  Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[13]  B. Parsons,et al.  Localization in rat brain of binding sites for parkinsonian toxin MPTP: similarities with [3H]parygyline binding to monoamine oxidase , 1985, Brain Research.

[14]  M. Dubocovich,et al.  Quantitative autoradiography of 3H-nomifensine binding sites in rat brain. , 1985, Life sciences.

[15]  M. Yahr,et al.  Pargyline and deprenyl prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in monkeys. , 1984, European journal of pharmacology.

[16]  R. S. Burns,et al.  Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism , 1984, Nature.

[17]  R. Duvoisin,et al.  Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors , 1984, Nature.

[18]  T. Hökfelt,et al.  Chemical anatomy of the brain. , 1984, Science.

[19]  K. Chiba,et al.  Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. , 1984, Biochemical and biophysical research communications.

[20]  D. Jacobowitz,et al.  A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Langston,et al.  Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. , 1983, Science.

[22]  R. Schwarcz,et al.  Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. , 1983, Science.

[23]  Dr. Heinz Stephan,et al.  The Brain of the Common Marmoset (Callithrix jacchus) , 1980, Springer Berlin Heidelberg.

[24]  Sanford P. Markey,et al.  Chronic parkinsonism secondary to intravenous injection of meperidine analogues , 1979, Psychiatry Research.

[25]  J. Glowinski,et al.  Topographical distribution of dopaminergic innervation and of dopaminergic receptors in the rat striatum. I. Microestimation of [3H]dopamine uptake and dopamine content in microdiscs , 1976, Brain Research.

[26]  A. Herbet,et al.  Specificity of dopaminergic neuronal degeneration induced by intracerebral injection of 6-hydroxydopamine in the nigrostriatal dopamine system , 1976, Brain Research.

[27]  M. Dubocovich,et al.  Autoradiographic Visualization and Quantification of Dopamine Receptors and Uptake Sites in the Rat and Human CNS , 1986 .

[28]  D. Jacobowitz,et al.  Neurochemical and behavioral effects of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) in rat, guinea pig, and monkey. , 1984, Psychopharmacology bulletin.

[29]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[30]  W. Greenough,et al.  A stereotaxic atlas of the albino mouse forebrain. , 1980 .

[31]  L. Pellegrino,et al.  stereotaxic atlas of the rat brain , 1967 .